Navigation Links
Sinovac to Present at the Brean Murray, Carret & Co. All-Cap All-China Conference and the Roth China Discovery Tour 2008
Date:5/7/2008

BEIJING, May 7 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a leading provider of vaccines in China, today announced that Mr. Weidong Yin, CEO, and Ms. Helen Yang, International Business Manager, are scheduled to present at the Brean Murray, Carret & Co. All-Cap All-China Conference on Monday, May 19, 2008 at 10:15 a.m. Eastern Standard Time at the Waldorf Astoria in New York, NY.

Ms. Nan Wang, Vice President, and Ms. Vanessa Wu, Senior Financial Manager, are scheduled to present at the Roth China Discovery Tour 2008 the same day at 5:20 p.m. Beijing Time at the Regent Hotel in Beijing, China.

Web cast of the Company's presentation at the Brean Murray, Carret & Co. All-Cap All-China Conference will be available by going to the investor relations section of Sinovac's Web site at http://www.sinovac.com . A replay of the presentation will be available for 30 days.

About Sinovac

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. Sinovac's commercialized vaccines include Healive(R) (hepatitis A), Bilive(R) (combined hepatitis A and B), Anflu(R) (influenza) and Panflu(TM)(H5N1). Sinovac is currently developing Universal Pandemic Influenza vaccine and Japanese encephalitis vaccine. Additional information about Sinovac is available on its website, http://www.sinovac.com . To be added to our distribution list, please email: info@sinovac.com.

Safe Harbor Statement

This announcement contains forward-looking state
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Sinovac Biotech Holds Annual General Meeting
2. Sinovac Reports Fourth Quarter and Full Year 2007 Financial Results
3. Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2007 Financial Results
4. Sinovac Announces Adjournment of Annual General Meeting
5. Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
6. Sinovac Closes $9.75 Million Private Placement
7. Sinovac Reports Top-Line Preliminary Phase II Results of Pandemic Influenza (H5N1) Whole Viron Vaccine
8. Sinovac Requests Extension for Annual Shareholders Meeting
9. Sinovac Announces Postponement of Annual General Meeting
10. Entrust Chairman, President and CEO Bill Conner to Present at 8th Annual State of Technology Luncheon
11. Sigma-Aldrich to Present at the Baird 2008 Growth Stock Conference on Tuesday, May 13, 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... 25 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. ( SV...announced today that it executed,a joint venture (...e,Technology Co., Ltd. (Sinovac Dalian). The JV wi...man-use vaccines. Sinovac will contribute its expe...zing world-class vaccines; the,other party will br...
(Date:11/24/2009)...man . , Whether it,s CD packaging, container...ncy Identification) are increasingly finding their...label objects or goods and identify them automatic...an read and process the data contained in the labe...uction conditions of up to 100 degrees Celsius. Bu...
(Date:11/24/2009)...rk investment bank KTA Capital,s client Neuren Pha...l convertible note private placement with a U.S. i...rranged by KTA Capital as Neuren,s exclusive place... New York (PRWEB) November 23, 2009 -- The indepen...uot;KTA Capital") has announced that its clie...
(Date:11/24/2009)...IK, Iceland, November 24 ...nced that it has received notice from,the Nasdaq S...tock will be,suspended as of November 30, 2009 and...nd Exchange Commission, which will remove deCODE,s...ompany files an appeal to the Nasdaq,Listing Quali...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Intelligence inside metal components 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3
...asdaq:,NVAX) today announced that it will report i... release to be issued after 8:00 a.m. Eastern Time... conference call to discuss its,financial results ...l will,be hosted by Novavax President and Chief Ex...s of senior management. A question and answer,sess...
...May 28, 2008 at 8:00 am (Eastern) / 5:0...NGHAI, China, May 6 /Xinhua-PRNewswire/ -- WuXi Ph...rmaceutical, biotechnology and medical device,rese...ations in China and,the United States, today annou...lts for the first quarter 2008 after the US market...
...Supported by a Grant from Otsuka ... May 6 The American Psychiatric,Foundation (APF) ...dividual,as the recipients of the fifth annual APF...awards were presented at the 2008 APF Annual Benef...dual was presented a plaque,along with an award of...
Other Biology Technology:Novavax Announces Release Date of 2008 First Quarter Financial Results and Investor Conference Call 2WuXi PharmaTech Schedules First Quarter 2008 Earnings Release on Tuesday, May 27, 2008 2American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 2American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 3American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 4American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 5
(Date:11/23/2009)...search presents strong evidence that the "synergis... traffic-related pollution and indoor endotoxin ca... other exposure alone. , Environmental health ...llege of Medicine have shown that children exposed...and indoor endotoxin during early life are six tim...
(Date:11/23/2009)... the Wildlife Conservation Society says that weste... Republic of Congopart of the "mother lode" of mor...coming increasingly threatened by growing humans a...otection of the swamp forests adjacent to the sout...ent surveys confirmed that high densities of the g...
(Date:11/23/2009)...he only swine vaccine available for the H1N1 virus...with the virus. The vaccination marks the first ti... with the pandemic flu., Iowa State University,s...ed the vaccine this summer and has been shipping p... and Illinois for several weeks., The latest vac...
Breaking Biology News(10 mins):Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Helix BioPharma Closes Private Placement 13918 1Helix BioPharma Closes Private Placement 13918 2Helix BioPharma Closes Private Placement 13918 3Making connections the key to overcoming shame 56491 1Making connections the key to overcoming shame 56491 2JDRF funded studies show regular CGM use increases diabetes control for all age groups 9833 1JDRF funded studies show regular CGM use increases diabetes control for all age groups 9833 2JDRF funded studies show regular CGM use increases diabetes control for all age groups 9833 3JDRF funded studies show regular CGM use increases diabetes control for all age groups 9833 4JDRF funded studies show regular CGM use increases diabetes control for all age groups 9833 5
...tion of an Inuit village already underway, some 40...are convening in Alaska for a UN-affiliated confer...nal knowledge can be used to both mitigate and ada...mpolar Council, the Indigenous Peoples, Global Sum...engthen the communities, participation in and arti...
...warmer from 18,700 to 10,000 years ago, juniper tr...obbing packrats of their favorite food. Now, Unive...r detoxification genes that let the rodents eat to... was either eat it or move out," says biology Prof...published online Tuesday, April 7 in the journal ...
... cancer, one of the most fatal cancers, due to the...ffective therapies: Johns Hopkins University patho... growth factor receptor aberrantly active in appro...rs studied. , In a presentation April 18, at E...y explained why this finding and related work in h...
Other Biology News:Indigenous peoples at world summit to share climate change observations, coping techniques 2Indigenous peoples at world summit to share climate change observations, coping techniques 3Indigenous peoples at world summit to share climate change observations, coping techniques 4Indigenous peoples at world summit to share climate change observations, coping techniques 5Indigenous peoples at world summit to share climate change observations, coping techniques 6Poison: It's what's for dinner 2Poison: It's what's for dinner 3Poison: It's what's for dinner 4Poison: It's what's for dinner 5Newly discovered epidermal growth factor receptor active in human pancreatic cancers 2
PCP ELISA Kit, Single from Bio-Quant Inc.
Cotinine ELISA Kit, Single from Bio-Quant Inc.
...d IHC Protocol Development ,Antibody Titer and Opt...nimal or Human Cells and Tissues ,Double Antibody ...e Phosphatase, Immunogold, and Fluorescent detecti...otein Localization in Transgenic Animals ,Hundreds...
Detection Reagents; Design; Development and Application from QualTek Molecular Laboratories
Biology Products: